ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 248 filers reported holding ICU MED INC in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $70,858,601 | +13.0% | 596,704 | +2.1% | 0.06% | +11.5% |
Q1 2024 | $62,693,017 | +49.9% | 584,169 | +39.3% | 0.05% | +44.4% |
Q4 2023 | $41,825,071 | -18.6% | 419,341 | -2.9% | 0.04% | -23.4% |
Q3 2023 | $51,378,997 | -37.8% | 431,720 | -6.9% | 0.05% | -36.5% |
Q2 2023 | $82,599,797 | +7.1% | 463,549 | -0.9% | 0.07% | +2.8% |
Q1 2023 | $77,134,142 | +10.5% | 467,593 | +5.5% | 0.07% | +5.9% |
Q4 2022 | $69,802,695 | +22.0% | 443,248 | +16.6% | 0.07% | +13.3% |
Q3 2022 | $57,238,000 | +32.2% | 380,067 | +44.3% | 0.06% | +36.4% |
Q2 2022 | $43,308,000 | -15.5% | 263,448 | +14.5% | 0.04% | +2.3% |
Q1 2022 | $51,234,000 | -43.5% | 230,120 | -39.8% | 0.04% | -39.4% |
Q4 2021 | $90,726,000 | +6.5% | 382,314 | +4.7% | 0.07% | -4.1% |
Q3 2021 | $85,174,000 | +30.1% | 364,997 | +14.7% | 0.07% | +29.8% |
Q2 2021 | $65,484,000 | +9.0% | 318,227 | +8.8% | 0.06% | 0.0% |
Q1 2021 | $60,086,000 | -2.4% | 292,513 | +1.9% | 0.06% | -10.9% |
Q4 2020 | $61,592,000 | +36.9% | 287,173 | +16.7% | 0.06% | +20.8% |
Q3 2020 | $44,992,000 | +7.9% | 246,181 | +8.8% | 0.05% | +1.9% |
Q2 2020 | $41,695,000 | +25.2% | 226,223 | +37.1% | 0.05% | +2.0% |
Q1 2020 | $33,291,000 | +16.9% | 164,993 | +8.4% | 0.05% | +54.5% |
Q4 2019 | $28,479,000 | +28.6% | 152,199 | +9.7% | 0.03% | +22.2% |
Q3 2019 | $22,146,000 | +7809.3% | 138,760 | +12400.9% | 0.03% | – |
Q2 2019 | $280,000 | +0.4% | 1,110 | -4.9% | 0.00% | – |
Q1 2019 | $279,000 | -6.7% | 1,167 | -10.4% | 0.00% | – |
Q4 2018 | $299,000 | -29.0% | 1,303 | -12.5% | 0.00% | – |
Q3 2018 | $421,000 | -20.9% | 1,489 | -17.7% | 0.00% | -100.0% |
Q2 2018 | $532,000 | +4.9% | 1,810 | -9.9% | 0.00% | 0.0% |
Q1 2018 | $507,000 | +16.0% | 2,008 | -0.7% | 0.00% | 0.0% |
Q4 2017 | $437,000 | +6.8% | 2,022 | -8.0% | 0.00% | 0.0% |
Q3 2017 | $409,000 | +12.4% | 2,199 | +4.3% | 0.00% | – |
Q2 2017 | $364,000 | +24.7% | 2,109 | +10.1% | 0.00% | – |
Q1 2017 | $292,000 | +42.4% | 1,915 | +37.7% | 0.00% | – |
Q4 2016 | $205,000 | -90.9% | 1,391 | -95.6% | 0.00% | -100.0% |
Q2 2013 | $2,255,000 | – | 31,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |